Generic medicines: Perceptions of pharmacists in Basrah, Iraq

HealthMED

Volumn 4, Issue 1, 2010, Pages 38-44

  Sharrad, Adheed Khalid ^a   Hassali, Mohamed Azmi ^a   Shafie, Asrul Akmal ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Bioequivalence; Generic medicine; Perceptions; Substitution

Indexed keywords

EID: 77949476349     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. FisherM.A.,Avorn J. Economic consequences of underuse of generic drugs:Evidence from Medicaid and Implications for prescription drug benefit plans.Health Ser Res 2003;38(4):pp.1051-64.
2. Ford N., Hoen E. Generic medicines are not substandard medicines. Lancent.2 002; 359 (9314) p.1351.
3. USAID, Pharmaceutical and Medical Products in Iraq,2007: 2-8.
4. USAID, Pharmaceutical and medical products in Iraq, 2007:51.
5. Karim, S., Pillai, G., Ziqubu-Page. (1996) 'Potential savings from generic prescribing and generic substitution in South Africa', Health Policy and Planning 1996, 11:198- 205.
6. Tilyard MW and Dovey SM: 'General practitioners' views on generic medication and substitution',.New Zealand Medical Journal 1990 , 103:318-320.
7. King DR and Kanavos P: Encouraging the use of generic medicines: Implications for transition economies. Croatian Medical Journal 2002, 43:462-469.
8. Lofgren H: Generics drugs: International trends and policy developments in Australia. Australian Health Review 2004, 27:39-48.
9. Moulds R: Generic prescribing - the pros. Australian Prescriber 1992, 15:50.
10. Messenger A: Substitution bitter pill to swallow for some: Australian Doctor 1995, June 4:16.
11. Donovan J: Is there a role for generic medicines in the pharmaceutical benefits scheme? Health Issues (Melbourne, Australia) 2003, 75:9-11.
12. Brand P, Clear P, Keen, S. 'Brand substitution', Australian Pharmacist 1995, 14: 646-649.
13. Kirking DM, Gaither CA, Ascione FJ and Welage LS: Physicians' individidual and organizational views on generic medications. Journal of the American Pharmaceutical Association 2001, 41:718-722.
14. McGavock H: Generic substitution Issues relating to the Australian experience. Pharmacoepidemiology and Drug Safety 2001,10:555-556.
15. Simon, H. A. Models of bounded rationality. Cambridge, Massachusetts: MIT Press 1982.3
16. Berg B 'Designing qualitative research', in Qualitative research methods for the social science.5th edn, Allyn and bacon,Boston,MA,1995: 37.
17. Smith F: Health services research methods in pharmacy-Qualitative Interviews. International Journal of Pharmacy 1998, 6: 97-108.
18. Smith F. Research methods in pharmacy practice. London: Pharmaceutical press; 2002. :119-122
19. Morse, J. and A. Field , Qualitative Research Methods for Health Professionals. Sage Publications, 2nd ed. London:1995:1 Australasian Medical Journal 2009, 1, 8, 58-64 63
20. Morse J: The significance of saturation. Qualitative Health Research 1995.5(2):147-9.
21. Glazer BG and Strauss AL: The discovery of grounded theory: strategies for qualitative research. New York: Aldine; 1997.
22. DeSilets L: Using icebreakers to open communication. J Contin Educ Nurs 2008, 39:292-293.
23. Burnard P: A method of analysing interview transcripts in qualitative research. Nurse Educ Today 1991, 11(6): 461-6.
24. Morse J and Field A: Qualitative research methods for health professionals. London: Sage Publications, 2nd ed.; 1995: 94
25. Segal R,Wantz D,Brusadin R.(1989) Pharmacists' decision making in the selection of generic pharmaceuticals.J Pharm Mark Manage, 4(1):75-91.
26. Sanborn MD,White SJ.Pharmacists' perceptions and practices regarding the purchase of multisource pharmaceuticals. Hosp Pharm 1993; 28(2): 104-6,109-13.
27. Hassali MA, David C. M. Kong., Kay Stewart. (2005) Generic medicines:perceptions of community pharmacists in Melbourne,Australia,Vol.1 4(3):p27-45.
28. Mott DA and Cline RR, (2000) Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care. 40(8): p. 662-74.
29. Ludin D. Moral hazard in physician prescription behavior.J Health Econ 2000;19(5):639-662.
30. Rosendahl I. (1994) Consumer on generic:some clues on their views from AARP. drug topics. AARP, 54s-56s.
31. Lagarce L.,Lusson-Brisset C. and Bruhat C.(2005) General practitioner perception for generic medicine. therapie,60,67-74.
32. WHO, (2003) International non proprietary names:revised procedure[online].Available from URL:http://www.who.int/gb/EB-WHA/PDF/ EB110/EEB1103.pdf[Accessed 2003 Mar 19].
33. Pharmacopoeia, B. (2003) British approved names: guiding principles [online].Available from URL:http://www.pharmacopoeia.org.uk/guiding. cfm[Accessed 2003 Mar 19.
34. Knowlton C. & Knapp D. (1994) community pharmacists help HMO cut drug costs. american pharmacy, 34, 36-42.
35. Creswell JW, Fetter MD, and Lvankova NV: Designing a mixed methods study in primary care. Annals of Family Medicine 2004, 2:7-12.